Zevra Therapeutics, Inc.
ZVRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$544 | $74,707 | -$3,099 | -$35,739 |
| Dep. & Amort. | $392 | $1,651 | $1,649 | $1,648 |
| Deferred Tax | -$433 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,771 | $2,464 | $3,115 | $4,018 |
| Change in WC | -$2,328 | -$7,289 | -$6,844 | $1,827 |
| Other Non-Cash | $4,851 | -$75,134 | -$3,043 | $11,996 |
| Operating Cash Flow | $4,709 | -$3,601 | -$8,222 | -$16,250 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$554 | -$213 | -$99 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$65,111 | -$150,353 | -$7,359 | -$14,595 |
| Inv. Sales/Matur. | $210,500 | $12,500 | $18,000 | $202 |
| Other Inv. Act. | -$149,411 | $150,000 | $0 | $8,922 |
| Investing Cash Flow | -$4,576 | $11,934 | $10,542 | -$5,471 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$372 | -$16,290 |
| Stock Issued | $0 | $1,381 | $1,979 | -$65,819 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,530 | $0 | $0 | $82,976 |
| Financing Cash Flow | $6,530 | $1,381 | $1,607 | $796 |
| Forex Effect | $64 | $658 | -$372 | $671 |
| Net Chg. in Cash | $6,727 | $10,372 | $3,555 | -$20,254 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $47,712 | $37,340 | $33,785 | $54,039 |
| End Cash | $54,439 | $47,712 | $37,340 | $33,785 |
| Free Cash Flow | $4,155 | -$3,814 | -$8,321 | -$16,250 |